"Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020." International Journal of Hyperthermia, 37(1), p. 1312
Disclosure statement
No potential conflict of interest was reported by the author(s).